We are live on ! Find out more
EARNEST Partners

EARNEST Partners Portfolio holdings

AUM $27.7B
1-Year Est. Return 52.44%
This Fund
S&P 500
This Quarter Est. Return
+30.37%
1 Year Est. Return
+52.44%
3 Year Est. Return
+92.17%
5 Year Est. Return
+120.28%
10 Year Est. Return
+519.8%
AUM
$14.5B
AUM Growth
+$2.88B
Cap. Flow
-$198M
Cap. Flow %
-1.37%
Top 10 Hldgs %
16.33%
Holding
1,216
New
16
Increased
105
Reduced
134
Closed
10

Top Buys

Rank Stock Value
1
MD icon
Pediatrix Medical
MD
+$111M
2
AROC icon
Archrock
AROC
+$56.8M
3
CBRL icon
Cracker Barrel
CBRL
+$46.8M
4
SABR icon
Sabre
SABR
+$46.5M
5
CNMD icon
CONMED
CNMD
+$43.5M

Sector Composition

Rank Sector Weight
1 Technology 21.74%
2 Financials 18.46%
3 Industrials 17.49%
4 Healthcare 12.3%
5 Consumer Discretionary 10.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DAR icon
1
Darling Ingredients
DAR
$10.1B
$323M 2.23%
5,601,684
-536,573
-9% -$25.6M
SMG icon
2
ScottsMiracle-Gro
SMG
$3.52B
$279M 1.93%
1,400,006
-7,850
-0.6% -$1.35M
FORM icon
3
FormFactor
FORM
$7.94B
$259M 1.79%
6,024,007
+931,073
+18% +$33.6M
CTLT
4
DELISTED
CATALENT, INC.
CTLT
$246M 1.7%
2,359,920
-181,850
-7% -$17.6M
TDY icon
5
Teledyne Technologies
TDY
$28.8B
$244M 1.69%
623,614
+28,886
+5% +$10.4M
CCMP
6
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$228M 1.58%
1,507,774
-3,799
-0.3% -$569K
ENTG icon
7
Entegris
ENTG
$20.6B
$202M 1.39%
2,099,972
-1,047,138
-33% -$91.5M
GATX icon
8
GATX Corp
GATX
$6.27B
$197M 1.36%
2,363,318
+126,761
+6% +$9.7M
RJF icon
9
Raymond James Financial
RJF
$34.5B
$196M 1.36%
3,078,144
+60,757
+2% +$3.48M
CWST icon
10
Casella Waste Systems
CWST
$5.96B
$190M 1.31%
3,060,783
+28,154
+0.9% +$1.67M
SABR icon
11
Sabre
SABR
$888M
$181M 1.25%
15,062,476
+5,024,953
+50% +$46.5M
HXL icon
12
Hexcel
HXL
$7.17B
$180M 1.24%
3,716,223
+331,804
+10% +$14.4M
SF
13
Stifel
SF
$12.3B
$178M 1.23%
5,302,394
+386,135
+8% +$11.5M
MPWR icon
14
Monolithic Power Systems
MPWR
$61.7B
$177M 1.23%
484,213
-291,461
-38% -$93.4M
FCFS icon
15
FirstCash
FCFS
$9.51B
$176M 1.22%
2,519,301
+167,074
+7% +$10.6M
CNMD icon
16
CONMED
CNMD
$1.5B
$176M 1.22%
1,575,336
+459,191
+41% +$43.5M
AIN icon
17
Albany International
AIN
$1.66B
$175M 1.21%
2,386,946
+477,287
+25% +$30.1M
TKR icon
18
Timken Company
TKR
$8.37B
$172M 1.19%
2,220,263
+3,171
+0.1% +$216K
HLI icon
19
Houlihan Lokey
HLI
$9.3B
$169M 1.17%
2,513,519
+72,622
+3% +$4.71M
CBRL icon
20
Cracker Barrel
CBRL
$1.24B
$169M 1.17%
1,279,327
+363,731
+40% +$46.8M
FELE icon
21
Franklin Electric
FELE
$4.45B
$163M 1.13%
2,360,713
+21,565
+0.9% +$1.42M
R icon
22
Ryder
R
$9.43B
$159M 1.1%
2,582,335
+138,251
+6% +$7.69M
RGA icon
23
Reinsurance Group of America
RGA
$16B
$159M 1.1%
1,374,140
+44,863
+3% +$5.01M
BIDU icon
24
Baidu
BIDU
$32.9B
$155M 1.07%
717,325
+9,084
+1% +$1.35M
WWW icon
25
Wolverine World Wide
WWW
$1.67B
$155M 1.07%
4,963,147
+644,118
+15% +$18.8M

Similar funds

EARNEST Partners's Q4 2020 Portfolio in Review

As of Q4 2020, EARNEST Partners held 1,216 positions worth $14.5B, up 25% from $11.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q4 2020: portfolio turnover was 2.1%. EARNEST Partners opened 16 new positions and exited 10, leaving the 1,216-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Industrials.

  • EARNEST Partners's largest Q4 2020 buy was TTM Technologies: 400,909 shares worth $5.53M.
  • EARNEST Partners added most to Pediatrix Medical in Q4 2020, an estimated $111M increase.
  • EARNEST Partners's biggest Q4 2020 reduction was American Equity Investment Life Holding Company, cutting an estimated $94.4M.
  • EARNEST Partners fully exited Immunomedics Inc in Q4 2020, selling an estimated $10K.
  • EARNEST Partners's ten largest holdings make up 16% of its $14.5B portfolio in Q4 2020.
  • EARNEST Partners opened 16 new positions and closed 10 in Q4 2020.
  • EARNEST Partners's portfolio value rose 25% quarter-over-quarter to $14.5B.

Based on EARNEST Partners's 13F filing for Q4 2020, filed 16 Feb 2021.